FDA backs BPA as study links it to heart disease, diabetes
Quote:
For the first time, a large, population-based study links a chemical in plastic baby bottles to heart disease and diabetes in humans.
Some scientists say the study — released today to coincide with a Food and Drug Administration meeting— shows that bisphenol A, or BPA, is too dangerous to allow in consumer products, especially those used by babies and pregnant women.
U.S. government regulators on Tuesday defended their assessment that BPA is safe.
"A margin of safety exists that is adequate to protect consumers, including infants and children, at the current levels of exposure," Laura Tarantino, a senior Food and Drug Administration scientist, told an expert panel that has been asked for a second opinion on the agency's assessment of BPA.
FDA officials said they are not dismissing such findings, and conceded that further research is needed. "We recognize the need to resolve the concerning questions that have been raised," said Tarantino. But the FDA is arguing that the studies with rats and mice it relied on for its assessment are more thorough than some of the human research that has raised doubts.
The FDA last month released a draft report concluding that BPA doesn't pose a risk at the levels to which people are exposed every day. That puts the agency at odds with the National Toxicology Program, which this month expressed "some concern" that BPA alters behavior, the brain and prostate gland in children, both before and after birth.
Some scientists say the study — released today to coincide with a Food and Drug Administration meeting— shows that bisphenol A, or BPA, is too dangerous to allow in consumer products, especially those used by babies and pregnant women.
U.S. government regulators on Tuesday defended their assessment that BPA is safe.
"A margin of safety exists that is adequate to protect consumers, including infants and children, at the current levels of exposure," Laura Tarantino, a senior Food and Drug Administration scientist, told an expert panel that has been asked for a second opinion on the agency's assessment of BPA.
FDA officials said they are not dismissing such findings, and conceded that further research is needed. "We recognize the need to resolve the concerning questions that have been raised," said Tarantino. But the FDA is arguing that the studies with rats and mice it relied on for its assessment are more thorough than some of the human research that has raised doubts.
The FDA last month released a draft report concluding that BPA doesn't pose a risk at the levels to which people are exposed every day. That puts the agency at odds with the National Toxicology Program, which this month expressed "some concern" that BPA alters behavior, the brain and prostate gland in children, both before and after birth.
The article is longer than that, that's just the intro...
I'm not overly concerned since I'm one who breastfeeds (and that seems to be the major source of "OMGITSPOISON!"), but I'm all for getting rid of as many unnecessary chemicals as possible.../shrug Anyway, thought some of the rest of you may be interested.
Nexa